CoMMpass from the Multiple Myeloma Research Foundation

cancer genomic

Description

The Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile study is the Multiple Myeloma Research Foundation (MMRF)’s landmark personalized medicine initiative. CoMMpass is a longitudinal observation study of around 1000 newly diagnosed myeloma patients receiving various standard approved treatments. The MMRF’s vision is to track the treatment and results for each CoMMpass patient so that someday the information can be used to guide decisions for newly diagnosed patients. CoMMpass checked on patients every 6 months for 8 years, collecting tissue samples, genetic, information, quality of life and various disease and clinical outcomes. The study has produced one of the largest genomic and clinical datasets of a single disease.

Update Frequency

Genomic Data Commons (GDC) is source of truth for this dataset; GDC offers monthly data releases, although this dataset may not be updated at every release.

License

NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies

Documentation

https://gdc.cancer.gov/about-gdc/contributed-genomic-data-cancer-research/foundation-medicine/multiple-myeloma-research-foundation-mmrf

Managed By

Center for Translational Data Science at The University of Chicago

See all datasets managed by Center for Translational Data Science at The University of Chicago.

Contact

dcf-support@datacommons.io

Usage Examples

Tools & Applications
Publications

Resources on AWS

  • Description
    RNA-Seq Gene Expression Quantification
    Resource type
    S3 Bucket
    Amazon Resource Name (ARN)
    arn:aws:s3:::gdc-mmrf-commpass-phs000748-2-open
    AWS Region
    us-east-1

Edit this dataset entry on GitHub

Home